Molecular Pathology of Cancer Group

Search for publications

Only original articles, editorials, guidelines.

  • Trigo J, García-Cosío M, García-Castaño A, Gomà M, Mesia-Nin R, Ruiz-Bravo E, Soria-Rivas A, Castillo P, Braña-García I, Alberola-Ferranti M.

    Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-022-02856-1]

  • Ranz-Colio Á, Almeida-Parra F, De Leyva-Moreno P, Cárdenas-Serres C, García-Cosío M, Acero-Sanz J.

    Navigation-guided resection of locally advanced midface malignancies. Does it improve the safety of oncologic resection?

    ORAL ONCOLOGY . 143: 106455-106455.

    [doi:10.1016/j.oraloncology.2023.106455]

  • Jesús CP, Alfonso CS, Belén PM, Jose Antonio DR, Odile AI, Eva María GA, Serrano Domingo JJ.

    Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity.

    CURR ONCOL REP . : .

    [doi:10.1007/s11912-023-01434-0]

  • Salge-Arrieta FJ, Vior-Fernández C, Lee P, Reguero-Callejas ME, Pian-Arias HG, Martínez-San Millán JS, Carrasco-Moro R.

    Giant fronto-spheno-orbitary juvenile psammomatoid ossifying fibroma: Case report and literature review.

    CHILDS NERVOUS SYSTEM . : .

    [doi:10.1007/s00381-023-06206-6]

  • Pena-Burgos EM, Romio De Las Heras E, Bernabéu D, Iglesias-Urraca C, Reguero Callejas ME, Pozo-Kreilinger JJ.

    Giant Cell Tumor of the Rib: A Report of Two Patients.

    INT J SURG PATHOL . : .

    [doi:10.1177/10668969241256119]

  • Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.

    Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae284]

  • Büttner T, Rizzo M, Bernal Vaca L, Molina-Cerrillo J, Alonso-Gordoa T, Juárez A, Buchler T, Seront E, Kucharz J, Gandur Quiroga MN, Bourlon MT, Bögemann M, Kopecky J, Rescigno P, Fiala O, Rodriguez-Vida A, Myint ZW, Ürün Y, Scagliarini S, Poprach A, Matthews D, Li H, Rizzo A, Mosca A, Lenci E, Melichar B, Wenzel M, Mandell P, Massari F, Antonarakis ES, Santoni M.

    Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.

    PROSTATE CANCER P D . : .

    [doi:10.1038/s41391-025-01067-3]

  • Alonso-Gordoa T, Fernández-Calvo O, García-Carbonero I, Álvarez-Rodríguez S, Sánchez-Escribano R, Anguera G, González-Del-Alba A, Gallardo E, Cacho D, Vidal N, Pinto Á, Perezagua C, Zafra-Poves M, Cassinello J, Rodriguez-Vida A, López-Campos F, Vázquez-Estévez S.

    Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter study.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-04174-8]

  • Ruz-Caracuel I, Alonso-Gordoa T, Hernández S, Hernando J, Rodrigo-Calvo MT, Jimenez-Fonseca P, Quiceno-Arias HD, Lorenzo-Lorenzo I, Bella-Cueto MR, Iglesias C, Cameselle-Teijeiro JM, Capdevila J.

    SEAP-GETNE consensus on prognostic and predictive molecular biomarkers in thyroid cancer.

    REVISTA ESPANOLA DE PATOLOGIA . 59(2): 100859-100859.

    [doi:10.1016/j.patol.2026.100859]

  • Garcia-Carbonero R, Benavent M, Jimenez-Fonseca P, Alonso-Gordoa T, Teulé A, Custodio A, Tafuto S, La Casta A, Spada F, López C, Ibrahim T, Iranzo V, García-Alfonso P, González-Flores E, Villanueva Silva MJ, Grande E, Panzuto F, Crespo G, Navarro M, Castellano D, Hernando J, Morales-Herrero R, Iglesias Álvarez G, Soldevilla B, Capdevila J.

    Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

    JOURNAL OF CLINICAL ONCOLOGY . : .

    [doi:10.1200/JCO-25-01808]

  • Lázaro-Navas I, Mur-Molina B, Villalobos-Baeza EB, Cortés-Salgado A, Pailos RH, Díaz-Soto EM, Fernández-Pardo TE, López-González L, Valcárcel-Linares D.

    Effectiveness of radiofrequency therapy combined with pelvic floor muscle training in breast cancer survivors with genitourinary syndrome of menopause: a study protocol.

    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY . 320: 115010-115010.

    [doi:10.1016/j.ejogrb.2026.115010]

  • Moreno-Moreno E, Caniego-Casas T, Ruz-Caracuel I, Carretero-Barrio I, Cabezas-López E, Cortés-Salgado A, Mendiola M, Redondo A, Muriel A, Hardisson D, Palacios J, Pérez-Mies B.

    MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society . 36(4): 104563-104563.

    [doi:10.1016/j.ijgc.2026.104563]